Please be advised that as a precautionary measure to slow the spread of the Coronavirus (COVID-19) within our community as advised by our state and local government officials, effective Friday, March 20, 2020, our IKS Team will begin working remotely for an indefinite period. We have equipped our team with laptops, full remote file access, case management software, and all needed online tools to create, collaborate, and get work done for our clients. Please direct communication to us thru our detailed voice mail system at (402) 391-4000, emails to gmueller@inserra.com, clkkelley@inserra.com or rsewell@inserra.com, or by fax to 402-391-4039, and our Team will continue to promptly address any needs or questions that you have for us! We will let you know when we are able to move back into our office, and stay safe and home if you can until we see you in person once again.
Thanks, Craig and Ryan
Avandia Manufacturer
/in Blog /by John InserraWhile the total settlement has not been made public the complaint about pharmaceutical companies has been marketing of drugs for conditions not approved by the FDA.
Consumer Product Recall for Another Gel Fuel
/in Blog /by John Inserra“FOR IMMEDIATE RELEASE
October 25, 2011
Release #12-020 Firm’s Recall Hotline: (877) 558-1511
CPSC Recall Hotline: (800) 638-2772
CPSC Media Contact: (301) 504-7908
Evergreen Enterprises Recalls Pourable Gel Fuel Due to Burn and Flash Fire Hazards
WASHINGTON, D.C. – The U.S. Consumer Product Safety Commission, in cooperation with the firm named below, today announced a voluntary recall of the following consumer products. Consumers should stop using recalled products immediately unless otherwise instructed. It is illegal to resell or attempt to resell a recalled consumer product. Read more
New findings about the drug YAZ
/in Blog /by John InserraThe Washington Post reports: A new study released by the Food and Drug Administration reviewed the medical history of more than 800,000 U.S. women taking different forms of birth control between 2001 and 2007. On average, woman taking Yaz had a 75 percent greater chance of experiencing a blood clot than women taking older birth control drugs.
Transvaginal Mesh
/in Blog /by John InserraHave you experienced complications with vaginal mesh implants?
In the last three years, the Food and Drug Administration says it has received nearly 3,000 reports of complications from transvaginal mesh.
Vaginal Mesh Implant Complications include:
This is what we are told by experts:
Liability depends in part on the vaginal/pelvic floor anatomy
If you or someone you know has or is having a problem with transvaginal mesh, you should contact us to discuss whether you have a potential claim for compensation
What Organizations Pay to Lobby
/in Blog /by John InserraOut of pure curiosity, I was wondering what some of the organizations I belong to paid lobbyist. I came across a website that allowed me to search all kinds of organizations and what they paid to lobbyists. If you believe that money buys influence, you can really see who is doing the buying. According to the website, 2.21 billion dollars was spent last year in reported lobbying costs. My lawyer groups spent 25 million lobbying, which is a lot of money, but is .01% of the total amount.